Related stories
Coloplast Lowers Annual Organic Growth Target Through 2030 to 5–7%
Coloplast lowered its target for annual organic growth through 2030 to 5–7%.
M impact | EARNINGS | Nov 02, 2026, 04:23 PM UTC
Anthropic IPO Filing Shows 1,127% Revenue Surge and Profit Erased
Anthropic filed amended IPO paperwork disclosing third-quarter results, including a 1,127% revenue surge and computing costs that erased its profit.
M impact | EARNINGS | Nov 02, 2026, 04:23 PM UTC
Coloplast forecasts FY organic growth of 5–7%
M impact | EARNINGS | Nov 02, 2026, 04:19 PM UTC
Coloplast Revises Financial Ambition Through 2030 and FY 2026/27 Guidance
Coloplast announced a revised financial ambition towards 2030 and FY 2026/27 guidance.
M impact | EARNINGS | Nov 02, 2026, 04:19 PM UTC
Tauron Reports Preliminary Q3 EBIT of 1.12 Billion Zlotys
M impact | EARNINGS | Nov 02, 2026, 04:13 PM UTC
Tauron Reports Preliminary Q3 EBITDA of 1.82 Billion Zlotys
M impact | EARNINGS | Nov 02, 2026, 04:13 PM UTC